Cargando…

Negative Regulation of T Cell Proliferation and Interleukin 2 Production by the Serine Threonine Kinase Gsk-3

Glycogen synthase kinase (GSK)-3 is a protein serine/threonine kinase that regulates differentiation and cell fate in a variety of organisms. This study examined the role of GSK-3 in antigen-specific T cell responses. Using resting T cells from P14 T cell receptor (TCR)-transgenic mice (specific for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohteki, Toshiaki, Parsons, Michael, Zakarian, Arsen, Jones, Russell G., Nguyen, Linh T., Woodgett, James R., Ohashi, Pamela S.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1887707/
https://www.ncbi.nlm.nih.gov/pubmed/10880530
_version_ 1782133679046262784
author Ohteki, Toshiaki
Parsons, Michael
Zakarian, Arsen
Jones, Russell G.
Nguyen, Linh T.
Woodgett, James R.
Ohashi, Pamela S.
author_facet Ohteki, Toshiaki
Parsons, Michael
Zakarian, Arsen
Jones, Russell G.
Nguyen, Linh T.
Woodgett, James R.
Ohashi, Pamela S.
author_sort Ohteki, Toshiaki
collection PubMed
description Glycogen synthase kinase (GSK)-3 is a protein serine/threonine kinase that regulates differentiation and cell fate in a variety of organisms. This study examined the role of GSK-3 in antigen-specific T cell responses. Using resting T cells from P14 T cell receptor (TCR)-transgenic mice (specific for the lymphocytic choriomeningitis virus and H-2D(b)), we demonstrated that GSK-3β was inactivated by serine phosphorylation after viral peptide–specific stimulation in vitro. To further investigate the role of GSK-3, we have generated a retroviral vector that expresses a constitutively active form of GSK-3β that has an alanine substitution at the regulatory amino acid, serine 9 (GSK-3βA9). Retroviral transduction of P14 TCR–transgenic bone marrow stem cells, followed by reconstitution, led to the expression of GSK-3βA9 in bone marrow chimeric mice. T cells from chimeric mice demonstrate a reduction in proliferation and interleukin (IL)-2 production. In contrast, in vitro assays done in the presence of the GSK-3 inhibitor lithium led to dramatically prolonged T cell proliferation and increased IL-2 production. Furthermore, in the presence of lithium, we show that nuclear factor of activated T cells (NF-AT)c remains in the nucleus after antigen-specific stimulation of T cells. Together, these data demonstrate that GSK-3 negatively regulates the duration of T cell responses.
format Text
id pubmed-1887707
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-18877072008-04-16 Negative Regulation of T Cell Proliferation and Interleukin 2 Production by the Serine Threonine Kinase Gsk-3 Ohteki, Toshiaki Parsons, Michael Zakarian, Arsen Jones, Russell G. Nguyen, Linh T. Woodgett, James R. Ohashi, Pamela S. J Exp Med Original Article Glycogen synthase kinase (GSK)-3 is a protein serine/threonine kinase that regulates differentiation and cell fate in a variety of organisms. This study examined the role of GSK-3 in antigen-specific T cell responses. Using resting T cells from P14 T cell receptor (TCR)-transgenic mice (specific for the lymphocytic choriomeningitis virus and H-2D(b)), we demonstrated that GSK-3β was inactivated by serine phosphorylation after viral peptide–specific stimulation in vitro. To further investigate the role of GSK-3, we have generated a retroviral vector that expresses a constitutively active form of GSK-3β that has an alanine substitution at the regulatory amino acid, serine 9 (GSK-3βA9). Retroviral transduction of P14 TCR–transgenic bone marrow stem cells, followed by reconstitution, led to the expression of GSK-3βA9 in bone marrow chimeric mice. T cells from chimeric mice demonstrate a reduction in proliferation and interleukin (IL)-2 production. In contrast, in vitro assays done in the presence of the GSK-3 inhibitor lithium led to dramatically prolonged T cell proliferation and increased IL-2 production. Furthermore, in the presence of lithium, we show that nuclear factor of activated T cells (NF-AT)c remains in the nucleus after antigen-specific stimulation of T cells. Together, these data demonstrate that GSK-3 negatively regulates the duration of T cell responses. The Rockefeller University Press 2000-07-03 /pmc/articles/PMC1887707/ /pubmed/10880530 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Original Article
Ohteki, Toshiaki
Parsons, Michael
Zakarian, Arsen
Jones, Russell G.
Nguyen, Linh T.
Woodgett, James R.
Ohashi, Pamela S.
Negative Regulation of T Cell Proliferation and Interleukin 2 Production by the Serine Threonine Kinase Gsk-3
title Negative Regulation of T Cell Proliferation and Interleukin 2 Production by the Serine Threonine Kinase Gsk-3
title_full Negative Regulation of T Cell Proliferation and Interleukin 2 Production by the Serine Threonine Kinase Gsk-3
title_fullStr Negative Regulation of T Cell Proliferation and Interleukin 2 Production by the Serine Threonine Kinase Gsk-3
title_full_unstemmed Negative Regulation of T Cell Proliferation and Interleukin 2 Production by the Serine Threonine Kinase Gsk-3
title_short Negative Regulation of T Cell Proliferation and Interleukin 2 Production by the Serine Threonine Kinase Gsk-3
title_sort negative regulation of t cell proliferation and interleukin 2 production by the serine threonine kinase gsk-3
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1887707/
https://www.ncbi.nlm.nih.gov/pubmed/10880530
work_keys_str_mv AT ohtekitoshiaki negativeregulationoftcellproliferationandinterleukin2productionbytheserinethreoninekinasegsk3
AT parsonsmichael negativeregulationoftcellproliferationandinterleukin2productionbytheserinethreoninekinasegsk3
AT zakarianarsen negativeregulationoftcellproliferationandinterleukin2productionbytheserinethreoninekinasegsk3
AT jonesrussellg negativeregulationoftcellproliferationandinterleukin2productionbytheserinethreoninekinasegsk3
AT nguyenlinht negativeregulationoftcellproliferationandinterleukin2productionbytheserinethreoninekinasegsk3
AT woodgettjamesr negativeregulationoftcellproliferationandinterleukin2productionbytheserinethreoninekinasegsk3
AT ohashipamelas negativeregulationoftcellproliferationandinterleukin2productionbytheserinethreoninekinasegsk3